Trademark: 97068643
Word
EMERALD THERAPEUTICS
Status Date
Wednesday, October 4, 2023
Filing Date
Monday, October 11, 2021
Published for Opposition
Tuesday, August 23, 2022
5 Pharmaceutical preparations used to treat viral infections; pharmaceutical preparations, namely, nucleic acids for therapeutic use; pharmaceutical preparations used to detect and regulate target polynucleotides
Oct 6, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 4, 2023
Sou Extension 2 Granted
Oct 4, 2023
Sou Extension 2 Filed
Oct 4, 2023
Sou Teas Extension Received
Apr 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 17, 2023
Sou Extension 1 Granted
Apr 17, 2023
Sou Extension 1 Filed
Apr 17, 2023
Sou Teas Extension Received
Oct 18, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 23, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 23, 2022
Published For Opposition
Aug 3, 2022
Notification Of Notice Of Publication E-Mailed
Jul 15, 2022
Approved For Pub - Principal Register
Jul 15, 2022
Examiner's Amendment Entered
Jul 15, 2022
Notification Of Examiners Amendment E-Mailed
Jul 15, 2022
Examiners Amendment E-Mailed
Jul 15, 2022
Examiners Amendment -Written
Jul 14, 2022
Notification Of Non-Final Action E-Mailed
Jul 14, 2022
Non-Final Action E-Mailed
Jul 14, 2022
Non-Final Action Written
Jul 14, 2022
Assigned To Examiner
Apr 15, 2022
Teas Change Of Correspondence Received
Apr 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 2, 2021
New Application Office Supplied Data Entered
Oct 14, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
